查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573176

Cat 药品市场：依产品类型、健康状况、给药途径- 2025-2030 年全球预测

Cat Medicines Market by Product Type (Non-Prescription Medicines, Prescription Medicines), Health Condition (Digestive Health, Immune System Support, Joint Health), Route Of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年猫科药物市场价值为153.5亿美元，预计到2024年将达到161.2亿美元，复合年增长率为6.31%，到2030年将达到235.6亿美元。

猫科药物市场包括多种用于诊断、治疗和预防家猫疾病和健康问题的药物。该细分市场包括抗寄生虫药物、抗生素和疫苗，为跳蚤、肠道寄生虫和上呼吸道感染疾病等常见猫科疾病提供解决方案。伴同性动物世界的激增以及人们对宠物健康和保健意识的不断增强证实了这个市场的需求。应用范围从非处方药到处方药，为宠物饲主、兽医和动物收容所等最终用户提供服务。影响成长的主要因素是宠物人性化的趋势，饲主将宠物视为家庭成员，增加了投资优质有效药物的意愿。此外，兽医诊断和生物技术的进步使得更有针对性的治疗方法的开发成为可能，创造了利润丰厚的商机。公司可以透过投资研发来开发创新解决方案，例如个人化医疗以及天然和永续配方，从而利用这些趋势。然而，市场开拓面临动物用药品核准严格法律规范、研发高成本挑战。此外，新兴市场的认知度低和无障碍度也是主要障碍。製药公司和兽医院之间的策略联盟可以成为一种富有成效的市场拓展手段。创新可以围绕着开发药物来提高疗效、减少副作用或针对当前未满足的临床需求，例如猫的衰老或慢性疾病。儘管这个市场挤满了现有企业，竞争也很激烈，但对于专注于特定问题（例如猫过敏或新的药物输送机制）的利基新参与企业来说，也有空间。利用数位平台进行客户参与和教育还可以在这个充满活力但充满挑战的市场环境中开闢新的管道。

主要市场统计
基准年[2023] 153.5亿美元
预测年份 [2024] 161.2亿美元
预测年份 [2030] 235.6亿美元
复合年增长率（%） 6.31%

市场动态：揭示快速发展的猫科药物市场的关键市场洞察

供需的动态交互作用正在改变猫科动物药品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 线上兽医药房服务的扩展使猫药离家更近
    • 支持宠物健康和安全标准的政府法规影响市场成长
    • 涵盖猫治疗费用的宠物保险的增加推动了市场需求
    • 开发创新的药物传输系统以促进猫科药物的管理
  • 市场限制因素
    • 消费者对猫咪定期兽医护理重要性的认识有限，尤其是在发展中地区。
    • 新猫药的核准和商业化的严格监管要求限制了产品的可用性。
  • 市场机会
    • 针对宠物照护市场整体健康的创新猫保健补充品
    • 针对常见猫科疾病的先进处方药，疗效已被证实
    • 针对具有环保意识的饲主的永续且环保的猫药
  • 市场挑战
    • 对药物疗效和副作用的担忧影响市场引入

波特的五力：驾驭猫科药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解猫科药物市场的外部影响

外部宏观环境因素在塑造猫科动物药品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解猫医药市场的竞争状况

对猫科动物药品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵猫科药物市场供应商的绩效评估

FPNV定位矩阵是评估猫科药品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了猫药市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对猫科动物药品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大线上兽药服务进一步改善猫科药物的获取
      • 优先考虑宠物健康和安全标准的政府法规影响市场成长
      • 涵盖猫治疗费用的宠物保险的增加推动了市场需求
      • 开发创新的药物输送系统，以更轻鬆地给猫用药
    • 抑制因素
      • 消费者对猫咪定期兽医护理重要性的认识有限，尤其是在发展中地区
      • 新猫药的核准和商业化的严格监管要求限制了产品的可用性
    • 机会
      • 创新的猫保健补充品瞄准宠物护理市场的整体健康
      • 先进的处方药，已被证实对猫的常见疾病有效
      • 为具有环保意识的宠物饲主提供永续且环保的猫药
    • 任务
      • 对药物功效和副作用的担忧影响市场采用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 Cat 药品市场：依产品类型

  • 无处方笺药物
    • 急救用品
    • 草药疗法
    • 食品补充品
    • 非处方止痛药
    • 局部治疗
  • 处方药
    • 发炎药
    • 抗生素
    • 荷尔蒙药物
    • 止痛药
    • 疫苗

第 7 章按健康状况分類的 Cat 药品市场

  • 消化器官系统健康
    • 膳食纤维补充品
    • 益生菌
  • 免疫系统支持
    • 抗氧化剂
  • 关节健康
    • 葡萄糖胺
  • 皮肤和毛皮健康
    • 缓解过敏
    • 欧米伽脂肪酸

第八章猫科药物市场：依给药途径

  • 可注射的
    • 疫苗
  • 口服
    • 液体
    • 药片
  • 话题
    • 奶油
    • 喷
  • 经皮的
    • 修补

第九章 Cat 美洲药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太猫科药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲猫药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-9A6A6F297DE3

The Cat Medicines Market was valued at USD 15.35 billion in 2023, expected to reach USD 16.12 billion in 2024, and is projected to grow at a CAGR of 6.31%, to USD 23.56 billion by 2030.

The cat medicines market encompasses a broad range of pharmaceutical products designed to diagnose, treat, and prevent diseases and health issues in domestic cats. This segment includes antiparasitics, antibiotics, and vaccines, offering solutions for common feline conditions such as fleas, intestinal worms, and upper respiratory infections. The growing adoption of companion animals worldwide and the increasing awareness of pet health and wellness underscore the necessity of this market. Applications range from over-the-counter medications to prescription drugs, serving end-users such as pet owners, veterinarians, and animal shelters. A major factor influencing growth is the rising trend of pet humanization, where owners treat pets as family members, thus increasing their willingness to invest in premium and effective medications. In addition, advances in veterinary diagnostics and biotechnology have enabled the development of more targeted treatments, creating lucrative opportunities. Companies can capitalize on these trends by investing in R&D to develop innovative solutions such as personalized medicine or natural, sustainable drug formulations. However, market growth faces challenges from stringent regulatory frameworks governing animal drug approvals and the high costs associated with research and development. Additionally, the lack of awareness or accessibility in emerging markets also poses a significant hurdle. Strategic collaborations between pharmaceutical companies and veterinary clinics could be a fruitful avenue for market expansion. Innovations can revolve around developing drugs with improved efficacy, fewer side effects, or those that target currently unmet clinical needs-such as aging and chronic conditions in cats. The market is competitive with established players, but it also offers room for niche newcomers focusing on specific issues like feline allergies or novel drug delivery mechanisms. Harnessing digital platforms for customer engagement and education can also open new channels in this vibrant yet challenging market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 15.35 billion
Estimated Year [2024] USD 16.12 billion
Forecast Year [2030] USD 23.56 billion
CAGR (%) 6.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cat Medicines Market

The Cat Medicines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of online veterinary pharmacy services making cat medicines more accessible
    • Government regulations favoring pet health and safety standards influencing market growth
    • Increase in pet insurance policies covering expenses for cat treatments driving market demand
    • Development of innovative drug delivery systems for easier administration of cat medications
  • Market Restraints
    • Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
    • Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
  • Market Opportunities
    • Innovative cat health supplements targeting holistic wellness in the pet care market
    • Advanced prescription medications for common feline illnesses with proven higher efficacy rates
    • Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
  • Market Challenges
    • Concerns over drug efficacy and side effects affect market adoption

Porter's Five Forces: A Strategic Tool for Navigating the Cat Medicines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cat Medicines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cat Medicines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cat Medicines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cat Medicines Market

A detailed market share analysis in the Cat Medicines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cat Medicines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cat Medicines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cat Medicines Market

A strategic analysis of the Cat Medicines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cat Medicines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Archer Daniels Midland Company, Bayer Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals, Elanco Animal Health, Heska Corporation, Hill's Pet Nutrition (Colgate-Palmolive), IDEXX Laboratories, Kindred Biosciences, Merck Animal Health, MWI Animal Health, Nestle Purina PetCare, PetIQ, Phibro Animal Health, Royal Canin, Vetoquinol, Virbac, and Zoetis.

Market Segmentation & Coverage

This research report categorizes the Cat Medicines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Non-Prescription Medicines and Prescription Medicines. The Non-Prescription Medicines is further studied across First Aid Products, Herbal Remedies, Nutritional Supplements, Over-The-Counter Pain Relief, and Topical Treatments. The Prescription Medicines is further studied across Anti-Inflammatory Drugs, Antibiotics, Hormonal Drugs, Pain Relievers, and Vaccines.
  • Based on Health Condition, market is studied across Digestive Health, Immune System Support, Joint Health, and Skin and Coat Health. The Digestive Health is further studied across Fiber Supplements and Probiotics. The Immune System Support is further studied across Antioxidants. The Joint Health is further studied across Glucosamine. The Skin and Coat Health is further studied across Allergy Relief and Omega Fatty Acids.
  • Based on Route Of Administration, market is studied across Injectable, Oral, Topical, and Transdermal. The Injectable is further studied across Vaccines. The Oral is further studied across Liquids and Tablets. The Topical is further studied across Creams and Sprays. The Transdermal is further studied across Patches.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of online veterinary pharmacy services making cat medicines more accessible
      • 5.1.1.2. Government regulations favoring pet health and safety standards influencing market growth
      • 5.1.1.3. Increase in pet insurance policies covering expenses for cat treatments driving market demand
      • 5.1.1.4. Development of innovative drug delivery systems for easier administration of cat medications
    • 5.1.2. Restraints
      • 5.1.2.1. Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
      • 5.1.2.2. Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative cat health supplements targeting holistic wellness in the pet care market
      • 5.1.3.2. Advanced prescription medications for common feline illnesses with proven higher efficacy rates
      • 5.1.3.3. Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over drug efficacy and side effects affect market adoption
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cat Medicines Market, by Product Type

  • 6.1. Introduction
  • 6.2. Non-Prescription Medicines
    • 6.2.1. First Aid Products
    • 6.2.2. Herbal Remedies
    • 6.2.3. Nutritional Supplements
    • 6.2.4. Over-The-Counter Pain Relief
    • 6.2.5. Topical Treatments
  • 6.3. Prescription Medicines
    • 6.3.1. Anti-Inflammatory Drugs
    • 6.3.2. Antibiotics
    • 6.3.3. Hormonal Drugs
    • 6.3.4. Pain Relievers
    • 6.3.5. Vaccines

7. Cat Medicines Market, by Health Condition

  • 7.1. Introduction
  • 7.2. Digestive Health
    • 7.2.1. Fiber Supplements
    • 7.2.2. Probiotics
  • 7.3. Immune System Support
    • 7.3.1. Antioxidants
  • 7.4. Joint Health
    • 7.4.1. Glucosamine
  • 7.5. Skin and Coat Health
    • 7.5.1. Allergy Relief
    • 7.5.2. Omega Fatty Acids

8. Cat Medicines Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Injectable
    • 8.2.1. Vaccines
  • 8.3. Oral
    • 8.3.1. Liquids
    • 8.3.2. Tablets
  • 8.4. Topical
    • 8.4.1. Creams
    • 8.4.2. Sprays
  • 8.5. Transdermal
    • 8.5.1. Patches

9. Americas Cat Medicines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cat Medicines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cat Medicines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aratana Therapeutics
  • 2. Archer Daniels Midland Company
  • 3. Bayer Animal Health
  • 4. Boehringer Ingelheim
  • 5. Ceva Sante Animale
  • 6. Dechra Pharmaceuticals
  • 7. Elanco Animal Health
  • 8. Heska Corporation
  • 9. Hill's Pet Nutrition (Colgate-Palmolive)
  • 10. IDEXX Laboratories
  • 11. Kindred Biosciences
  • 12. Merck Animal Health
  • 13. MWI Animal Health
  • 14. Nestle Purina PetCare
  • 15. PetIQ
  • 16. Phibro Animal Health
  • 17. Royal Canin
  • 18. Vetoquinol
  • 19. Virbac
  • 20. Zoetis

LIST OF FIGURES

  • FIGURE 1. CAT MEDICINES MARKET RESEARCH PROCESS
  • FIGURE 2. CAT MEDICINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CAT MEDICINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CAT MEDICINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CAT MEDICINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CAT MEDICINES MARKET DYNAMICS
  • TABLE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY FIRST AID PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CAT MEDICINES MARKET SIZE, BY OVER-THE-COUNTER PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CAT MEDICINES MARKET SIZE, BY HORMONAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CAT MEDICINES MARKET SIZE, BY PAIN RELIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CAT MEDICINES MARKET SIZE, BY FIBER SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CAT MEDICINES MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CAT MEDICINES MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CAT MEDICINES MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CAT MEDICINES MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CAT MEDICINES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CAT MEDICINES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CAT MEDICINES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CAT MEDICINES MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 265. TAIWAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 266. TAIWAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 267. TAIWAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 268. TAIWAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. THAILAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 278. THAILAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 279. THAILAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 280. THAILAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 281. THAILAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 289. VIETNAM CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. VIETNAM CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 291. VIETNAM CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 292. VIETNAM CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 293. VIETNAM CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 294. VIETNAM CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 316. DENMARK CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. DENMARK CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 318. DENMARK CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 319. DENMARK CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 320. DENMARK CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 321. DENMARK CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 322. DENMARK CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 323. DENMARK CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 324. DENMARK CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 325. DENMARK CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 326. DENMARK CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 327. DENMARK CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 328. DENMARK CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 329. EGYPT CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. EGYPT CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 331. EGYPT CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 332. EGYPT CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 333. EGYPT CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 334. EGYPT CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 335. EGYPT CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 336. EGYPT CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 337. EGYPT CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 338. EGYPT CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 339. EGYPT CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 340. EGYPT CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 341. EGYPT CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 342. FINLAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. FINLAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 344. FINLAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 345. FINLAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 346. FINLAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 347. FINLAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 348. FINLAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 349. FINLAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 350. FINLAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. FINLAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 352. FINLAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 353. FINLAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 354. FINLAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 355. FRANCE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. FRANCE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 357. FRANCE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD